Tag: TCT
Twelve-month PARADIGM study data demonstrate benefit of CGuard Embolic Prevention System...
InspireMD has announced 12-month follow up data from PARADIGM-101 study of the CGuard Embolic Prevention System (EPS), which were presented at the Transcatheter Cardiovascular...